Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988. Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702. Policy Forum Feb 2017 What Is the Relevance of Procedural Fairness to Making Determinations about Medical Evidence? Govind Persad, JD, PhD Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects. AMA J Ethics. 2017;19(2):183-191. doi: 10.1001/journalofethics.2017.19.2.pfor1-1702. Policy Forum Feb 2017 Seeking Legitimacy for DSM-5: The Bereavement Exception as an Example of Failed Process James E. Sabin, MD and Norman Daniels, PhD The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes. AMA J Ethics. 2017;19(2):192-198. doi: 10.1001/journalofethics.2017.19.2.pfor2-1702. Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806. Medicine and Society Feb 2017 The Case of Dr. Oz: Ethics, Evidence, and Does Professional Self-Regulation Work? Jon C. Tilburt, MD, MPH, Megan Allyse, PhD, and Frederic W. Hafferty, PhD Dr. Oz’s advice has raised ethical questions about medicine as a profession, its evidentiary standards, and its role in maintaining public trust. AMA J Ethics. 2017;19(2):199-206. doi: 10.1001/journalofethics.2017.19.2.msoc1-1702. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988.
Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702.
Policy Forum Feb 2017 What Is the Relevance of Procedural Fairness to Making Determinations about Medical Evidence? Govind Persad, JD, PhD Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects. AMA J Ethics. 2017;19(2):183-191. doi: 10.1001/journalofethics.2017.19.2.pfor1-1702.
Policy Forum Feb 2017 Seeking Legitimacy for DSM-5: The Bereavement Exception as an Example of Failed Process James E. Sabin, MD and Norman Daniels, PhD The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes. AMA J Ethics. 2017;19(2):192-198. doi: 10.1001/journalofethics.2017.19.2.pfor2-1702.
Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806.
Medicine and Society Feb 2017 The Case of Dr. Oz: Ethics, Evidence, and Does Professional Self-Regulation Work? Jon C. Tilburt, MD, MPH, Megan Allyse, PhD, and Frederic W. Hafferty, PhD Dr. Oz’s advice has raised ethical questions about medicine as a profession, its evidentiary standards, and its role in maintaining public trust. AMA J Ethics. 2017;19(2):199-206. doi: 10.1001/journalofethics.2017.19.2.msoc1-1702.